Officially, the FDA cites: Insufficient large-scale clinical trials Concerns about consistency, sourcing, and manufacturing standards The need to meet formal drug approval requirements Critics argue (fairly) that this system: Favors large pharmaceutical companies Makes it hard to approve naturally occurring peptides Leaves promising, low-risk compounds in regulatory limbo The short version: This FDA restrictive regulatory change of mind wasnt driven by a sudden safety scare, it was driven by regulatory process and economics
Dietary components that may influence the disturbed gut microbiota in chronic kidney disease
Ultimate Solutions Medical Spa serves patients throughout Stamford with the latest in metabolic medicine
-Glutamylcyclotransferase knockdown inhibits growth of lung cancer cells through G0/G1 phase arrest
It addresses everything from skin elasticity and hair health to inflammation reduction and accelerated tissue recovery
Anti-Aging: Support healthy skin, hair, and nails to look and feel your best